- Home
- DBVT vs IQ Comparison
DBVT vs IQ Comparison
Compare DBVT & IQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DBVT | IQ |
|---|---|---|
| Founded | 2002 | 2009 |
| Country | France | China |
| Employees | 90 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2014 | 2017 |
Fundamental Metrics
Financial Performance| Metric | DBVT | IQ |
|---|---|---|
| Price | $16.62 | $1.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $32.04 | $2.91 |
| AVG Volume (30 Days) | 199.1K | ★ 5.9M |
| Earning Date | 05-12-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.26 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,636,000.00 | N/A |
| Revenue This Year | $35.04 | $0.28 |
| Revenue Next Year | $2,360.78 | $3.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 35.77 | N/A |
| 52 Week Low | $8.48 | $1.03 |
| 52 Week High | $26.19 | $2.76 |
Technical Indicators
Market Signals| Indicator | DBVT | IQ |
|---|---|---|
| Relative Strength Index (RSI) | 29.09 | 36.91 |
| Support Level | $16.49 | N/A |
| Resistance Level | $16.95 | $1.26 |
| Average True Range (ATR) | 0.79 | 0.05 |
| MACD | -0.14 | 0.00 |
| Stochastic Oscillator | 6.76 | 12.50 |
Price Performance
Historical ComparisonAbout DBVT DBV Technologies S.A.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
About IQ iQIYI Inc.
Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.